Antibody or Antigen binding fragment isolated from the same that specifically binds interleukin (IL - 25 hjumana 2525); Pharmaceutical composition that comprises farmacéut; use of the compositionICA to treat a disease or Disorder associated with the activity or expression of IL - 25. (Divisional Application 201700703)

摘要

An isolated Fragment of Antibody or Antigen from the same Union binds specifically to human interleukin (IL) - 25 - 25),That includes a set of six Cor selected from the group consisting of: (a) SEC ID: 4,6,8, nos. 12, 14, 16; (o) SEC ID no: 20, 22, 24, 28, 30, 32; (c) SEC ID no: 36, 38, 40, 44, 46,48; (d) SEC ID no: 84, 86, 88, 92, 94, 96; (e) SEC ID no: 132, 134, 136, 140, 142, 144; (f) SEC ID no: 164, 166, 168, 172, 174, 176 and SEC (9); ID no: 228, 230, 232, 236, 238, 240.A Pharmaceutical composition comprising Said Antibody and Antigen or a fragment of a Union farmacÉuticamente acceptable carrier or diluent.Use of the pharmaceutical composition for treating a disease or Disorder associated with the activity or expression of irterleucina 25 (IL - 25) in a subject in need of such treatment.